AGIR a Dom

What AGIR a Dom does

AGIR à dom is a France-based home healthcare group founded in 1974 at CHU Grenoble by Professor Bernard Paramelle, originally as a respiratory insufficiency association. Operating as a Société à Mission since June 2022, the group functions as the country's leading associative PSAD (Prestataire de Santé à Domicile) with €65M in FY2024 revenue, 500+ employees, 20 agencies across 5 regions, and 46,000+ patients under active care. The group's core business delivers oxygen therapy, perfusion, nutrition, diabetes management (including insulin pumps and continuous glucose monitoring), sleep apnea treatment (CPAP/VNI), wound care, and stomatherapy services directly to patients' homes, reimbursed through the French social security system. The company is staffed by multidisciplinary field teams, 40% of whom are paramedical professionals, supported by a 24/7 technical hotline and the AGIweb secure portal for patient-prescriber data exchange.

The group's technology platform includes AGIweb (secure patient and prescriber portal), the Ordoclic ERP-to-AMELI PRO integration for prescription renewal, and IC@dom, a wholly-owned subsidiary authorized by ARS Auvergne-Rhône-Alpes for home-based clinical research in sleep apnea, insulin pumps, and long-term oxygen therapy. In 2022, AGIR à dom acquired OpenHealth Company (estimated €8M) for its 4 CNIL-authorized Health Data Warehouses, which process daily sales data from 12,000+ pharmacies (representing over 50% of the French network) and provide real-time medication consumption monitoring to ANSM under a contract renewed in 2023. Complementary subsidiaries include AXDOM (acquired 2018, PACA region home healthcare), Partition Santé (acquired 2019, perfusion/nutrition), and the founding Association AGIR à dom, which funds ~€500,000 annually in medical research (85%) and patient associations (15%) through its INNOVADOM program (€200,000/year grant pool).

Revenue is generated through three streams: managed home healthcare services reimbursed by French social security, health data monetization via OpenHealth (analytics, licensing, subscriptions to pharma and regulators), and professional services through IC@dom (clinical trials funded by research grants and pharma partnerships). Distribution is sales-led via direct field teams, hospital referral networks, and prescriber relationships, with marketing centered on medical congresses, paramedical events, and digital channels. The group received a minority equity investment in 2023 from Crédit Agricole Group (IDIA Capital Investissement, Crédit Agricole Alpes Développement, SOLIFARO) to fund territorial expansion and digital transformation. Recent product moves include a post-knee-prosthesis catheter pain management partnership with Clinique Mutualiste AÉSIO Santé (March 2026) and the 'Deviens capitaine de ton diabète' interactive educational game (November 2025).

Name

AGIR a Dom

Legal name

AGIR à dom Assistance SAS

Website

https://agiradom.com

Company type

Private

Founded year

1974

Operating status

Operating

Headcount range

251–500 employees

Short description

AGIR à dom is France's leading associative home healthcare provider (PSAD), delivering oxygen therapy, perfusion, nutrition, diabetes, and respiratory care to 46,000+ chronic and acute patients across 20 agencies in 5 regions, complemented by clinical research and health data analytics subsidiaries.

Ownership category

akta.pro rank

Product category

Home Healthcare Services

NAICS

Services for the Elderly and Persons with Disabilities (624120)

SIC

Services-Home Health Care Services (8082)

akta.pro primary industry

Chronic Disease Management & Remote Patient Monitoring (RPM) (HSABACAD)

Keywords

• Home healthcare services
• Respiratory therapy
• Infusion services
• Diabetes management
• Clinical investigation

Headquarters

HQ city

Meylan

HQ country

France

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Home Healthcare Services (PSAD): Prestataire de Santé à Domicile providing home healthcare services for chronic and acute diseases including respiratory care (oxygen therapy), perfusion, nutrition, and diabetes management. Services are reimbursed through French social security system.
2. Health Data Services: OpenHealth Company provides data analysis services to health authorities, pharmaceutical companies, researchers, and healthcare organizations. Revenue comes from analytics services, data licensing, and platform access subscriptions.
3. Clinical Investigation Services: IC@dom conducts clinical trials and research studies at patient homes, funded through research grants, pharmaceutical partnerships, and institutional funding

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Core offering

AGIR a Dom is a French home healthcare provider (PSAD) delivering oxygen therapy, perfusion, nutrition, diabetes management, sleep apnea treatment, wound care, and stomatherapy services to patients with chronic and acute conditions across 20 agencies in 5 regions. The group also operates clinical investigation (IC@dom) and health data analytics (OpenHealth Company) subsidiaries. Services are reimbursed through the French social security system and coordinated with prescribing physicians and hospitals.

Product overview

AGIR à dom operates as a multi-entity home health group offering a unified platform of services centered on its PSAD (Prestataire de Santé à Domicile) core business, complemented by specialized subsidiaries and the AGIweb digital portal. The portfolio includes: the main PSAD service providing oxygen therapy, perfusion, nutrition, diabetes, sleep apnea (PPC/VNI), wound care, and stomatherapy/urology services; IC@dom for clinical investigation at home; OpenHealth Company for health data processing and analytics; and AGIR à dom Association for research funding and patient support. The AGIweb portal connects patients and prescribers to the care ecosystem, while INNOVADOM funds innovation projects. Services span from acute post-operative care (nerve catheters) to chronic disease management spanning 50 years of expertise across 20 agencies in 5 regions.

Differentiator

Problem solved

Functional benefit

Brands

• AGIweb: Patient and prescriber portal providing secure access to health data and online prescription management
• IC@dom
• OpenHealth Company
• AGIR à dom Association
• INNOVADOM

Products and services

• AGIweb Secure online portal allowing patients to access their health data, track treatments, and manage appointments, while prescribers can follow patient data and sign prescriptions online.

Quantifiable outcome

• More than 95% patient satisfaction rate in surveys conducted by independent organisms
• +5 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Clinique Mutualiste AÉSIO Santé, Saint-ÉtiennecoreStrategic or Co-development Partner · 1 April 2025Since spring 2025, AGIR à dom and Clinique Mutualiste AÉSIO Santé have partnered to provide knee prosthesis patients with 4-day catheter-based pain management at home. This innovative care pathway allows patients to continue pain treatment at home after surgery, improving comfort and recovery. Over 120 patients have benefited from this program, achieving effective analgesia, early mobilization, and faster recovery.
• Various medical research institutions (eligible through INNOVADOM)minorStrategic or Co-development Partner · 1 January 2023INNOVADOM call for projects provides up to 200,000€/year to support research projects optimizing patient care pathways. Evaluation committee includes experts from CHU Grenoble Alpes.
• Dr Cécile Betry, CHU Grenoble AlpesminorStrategic or Co-development Partner · 1 November 2022Joint research study on diaboulimia (eating disorders in Type 1 diabetes patients) published in collaboration with endocrinology department.
• O2&Cie Urgence BPCOminorStrategic or Co-development Partner · 1 June 2022Partnership with BPCO (COPD) association for Tour BPCO cycling event supporting patients with chronic respiratory disease to practice cycling while receiving oxygen therapy.
• ANSM (Agence Nationale de Sécurité du Médicament)coreStrategic or Co-development Partner · 1 June 2022OpenHealth Company operates the real-time medication consumption monitoring platform for ANSM since 2008, renewed for 3 years in 2023. This is a critical public health data partnership.
• CHU Grenoble AlpescoreStrategic or Co-development Partner · 1 January 1974Long-standing partnership with CHU Grenoble Alpes including joint clinical research, diabetes studies, and medical education. Professor Bernard Paramelle founded AGIR à dom association at CHU Grenoble Alpes.
• ARSLA (Association pour la Recherche sur la Sclérose Latérale Amyotrophique)minorStrategic or Co-development PartnerPartnership with ALS association including annual event participation, patient support, research funding, and patient information sharing.
• Patient associations (various)minorStrategic or Co-development PartnerAGIR à dom Association allocates 15% of its 500,000€ annual donations to patient associations, supporting various chronic disease patient organizations.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Orkyn' (formerly Orkyn', Air Liquide Healthcare): One of the largest French PSADs, owned by Air Liquide, providing home oxygen therapy, ventilation, perfusion, nutrition, and diabetes services. Directly comparable to AGIR à dom in service portfolio and customer base (patients with chronic respiratory and metabolic diseases), with a national footprint that exceeds AGIR à dom's regional concentration.
• VitalAire (Air Liquide subsidiary): Air Liquide's historic home healthcare brand focused on oxygen therapy, sleep apnea (PPC), and ventilation. A direct competitor in the core respiratory PSAD segment where AGIR à dom derives the largest share of revenue, with a broader national service network and Air Liquide's equipment supply scale.
• Bastide Le Confort Médical: Listed French home healthcare and medical equipment provider (Euronext Paris) offering respiratory care, perfusion, nutrition, and home medical equipment. Comparable to AGIR à dom across PSAD service lines with public-market disclosure, geographic complementarity (stronger in southern France), and an adjacent medical equipment retail business.
• SOS Oxygène: Independent French PSAD specializing in home oxygen therapy, ventilation, sleep apnea, and respiratory insufficiency services. Directly comparable in mission and product mix to AGIR à dom's core respiratory offering, with a regional agency model similar to AGIR à dom's 20-agency footprint.
• Homeperf: French PSAD focused on home perfusion, parenteral nutrition, and IV antibiotic therapy services. Closely comparable to AGIR à dom's perfusion and nutrition segments (Partition Santé business), with national coverage and strong hospital discharge coordination partnerships.
• AMS (Assistance Médicale et Services): French home healthcare provider offering oxygen therapy, sleep apnea, perfusion, and nutrition services through regional agencies. Comparable to AGIR à dom in service mix and distribution model, typically competing in overlapping regions in central and western France.
• France Oxygène: Independent French PSAD specializing in home oxygen therapy and respiratory care with regional agency coverage. Direct competitor in the same chronic respiratory patient segment as AGIR à dom, with similar reimbursement-based economics.

Emerging players

• Cegedim Health Data Solutions: French health data and software company providing real-world evidence and analytics services. Comparable to AGIR à dom's OpenHealth Company subsidiary in health data monetization, with a broader electronic health record footprint and overlap with pharma customer relationships.

Broad incumbents

• IQVIA France: Global leader in clinical research, real-world evidence, and health data analytics with major operations in France. Comparable to IC@dom (clinical investigation at home) and OpenHealth in serving pharma and health authorities, with substantially broader international scale and a comprehensive service portfolio.

Regional players

• Nutricia (Danone Specialized Nutrition): European leader in medical nutrition providing enteral and parenteral nutrition products and home delivery services. Comparable to AGIR à dom's nutrition segment with complementary product portfolio; competes as a supplier rather than as a PSAD, but overlaps in the home enteral/parenteral nutrition patient pathway.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCSOgToFTHD5LpE4ZH5M1XiA/videos
• Facebookfacebook.com/GroupeAGIRadom
• LinkedInlinkedin.com/company/agir-a-dom-sas

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AGIR a Dom